PT  - JOURNAL ARTICLE
AU  - Zhang, Panpan
AU  - Wang, Tiandong
AU  - Xie, Sharon X.
TI  - Meta-analysis of several epidemic characteristics of COVID-19
AID  - 10.1101/2020.05.31.20118448
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.31.20118448
4099  - http://medrxiv.org/content/early/2020/06/03/2020.05.31.20118448.short
4100  - http://medrxiv.org/content/early/2020/06/03/2020.05.31.20118448.full
AB  - As the COVID-19 pandemic has strongly disrupted people’s daily work and life, a great amount of scientific research has been conducted to understand the key characteristics of this new epidemic. In this manuscript, we focus on four crucial epidemic metrics with regard to the COVID-19, namely the basic reproduction number, the incubation period, the serial interval and the epidemic doubling time. We collect relevant studies based on the COVID-19 data in China and conduct a meta-analysis to obtain pooled estimates on the four metrics. From the summary results, we conclude that the COVID-19 has stronger transmissibility than SARS, implying that stringent public health strategies are necessary.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. Zhang and Dr. Xie received support from the National Institute of Health (NIH) grant R01-NS102324.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A